CHBP induces stronger immunosuppressive CD127+ M-MDSC via erythropoietin receptor
Abstract Erythropoietin (EPO) is not only an erythropoiesis hormone but also an immune-regulatory cytokine. The receptors of EPO (EPOR)2 and tissue-protective receptor (TPR), mediate EPO’s immune regulation. Our group firstly reported a non-erythropoietic peptide derivant of EPO, cyclic helix B pept...
Main Authors: | Jiawei Li, Guowei Tu, Weitao Zhang, Yi Zhang, Xuepeng Zhang, Yue Qiu, Jiyan Wang, Tianle Sun, Tongyu Zhu, Cheng Yang, Ruiming Rong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-03448-7 |
Similar Items
-
MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
by: Christophe Vanhaver, et al.
Published: (2021-06-01) -
Long-Term Protection of CHBP Against Combinational Renal Injury Induced by Both Ischemia–Reperfusion and Cyclosporine A in Mice
by: Yufang Zhang, et al.
Published: (2021-07-01) -
Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer
by: Xinyu Tian, et al.
Published: (2018-06-01) -
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma
by: Mehreen Ishfaq, et al.
Published: (2021-02-01) -
CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients
by: Fatih M. Uckun, et al.
Published: (2021-09-01)